Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.

Researchers find that surges in COVID-19 case numbers are associated with deletions in the SARS-CoV-2 genome in an antigenic site of the spike protein. Some of these mutations are present in vaccine breakthrough infections or reinfections.

Functional profiling of immune cells uncovers targetable mechanisms underlying lung inflammation in severe COVID disease.

Glucometers are easy-to-use, cheap, and highly scalable. And they are 100 percent accurate at detecting SARS-CoV-2.

Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.

Skin symptoms are often the first, or only, symptom of COVID-19.

Benjamin Haibe-Kains and Rachelly Normand showcase how they use multi-omic approaches to fight both old and new diseases.

Structures made via cryo-EM give researchers insights into SARS-CoV-2, HIV, neurological disorders, cancer, and more.

Scientists use ELISAs to assess the immunity and etiology of immune responses to coronavirus during the COVID-19 pandemic.

The World Health Organization–led program will promote equity in addition to facilitating access to samples, a WHO official involved in the project tells The Scientist.

Researchers find traces of SARS-CoV-2 in the stool and blood of kids with the post–COVID-19 inflammatory disorder, and signs of increased intestinal permeability.

Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.

The recent news of consumers hoarding gasoline in the face of a brief closure of one of the world’s biggest petroleum pipelines is just the latest episode of panic buying since the COVID-19 pandemic started.

Meet some of the people featured in the June 2021 issue of The Scientist.

In addition to continued scruitiny of the SARS-CoV-2 virus, research on similar pathogens could aid in the fight against the COVID-19 pandemic and future disease outbreaks.

Some children who experience the severe inflammatory condition after COVID-19 may continue to experience milder problems such as muscle weakness or anxiety even after that period, according to a small observational study in the UK.

Two studies this month point to pooches’ quick detection of SARS-CoV-2 on material that touched the skin of infected participants, although the pups’ accuracy does not match that of RT-PCR.

Countries outside the US and Europe that are already used to long wait times for laboratory supplies are facing greater research disruptions than ever during the pandemic.

Two viruses from dogs and pigs were isolated from human patients, but neither was proven to cause severe disease or to transmit to other people.